Management and Outcomes of Abdominal Wall Reconstruction in Ehlers-Danlos Syndrome: A Scoping Review
Abstract
INTRODUCTION
The purpose of this study is to evaluate the current body of literature describing abdominal wall reconstruction management and outcomes in patients with Ehlers-Danlos Syndrome (EDS) to guide future surgical recommendations for this vulnerable population.
METHODS
In accordance with PRISMA-ScR guidelines, a scoping review was conducted in May 2026 using PubMed, Cochrane, Scopus, and Embase. We identified literature that discussed the operative management and postoperative outcomes of abdominal wall reconstruction in patients with EDS. Studies were screened and data were extracted by two independent reviewers. Data included study, patient, and operative characteristics, in addition to postoperative outcomes.
RESULTS
Nine studies (six case reports and three case series) comprising 28 patients in total were included in this study. The most reported reconstructive technique was mesh reinforcement, primarily synthetic mesh, and most commonly retromuscular or sublay positioning. Other described techniques included oversized mesh reinforcement (mean 399 cm2 mesh surface area for a mean defect size of 3 × 5 cm, reported in a single case series of 14 patients), meticulous suture technique, component separation, multilayer fascial closure, and flap-based reconstruction (specifically when a contaminated defect was unsuitable for mesh use). Dehiscence was reported in six of the nine studies, representing the most commonly reported complication. Hernia recurrence was rarely…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.